Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:50:22.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1. The page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-10T15:51:47.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with header and footer intact, indicating access to the study record is blocked.
    Difference
    18%
    Check dated 2026-09-19T19:09:11.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor version update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-29T20:24:09.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    A revision tag on the page updates to v3.6.5, replacing the previous v3.6.4. This signals a backend/template update rather than a substantive change to study details or participant information.
    Difference
    0.0%
    Check dated 2026-08-08T14:57:37.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a small behind-the-scenes update to the site. This does not alter the study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-25T07:38:58.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.